|
Methyl 5-{[(2E)-3-(furan-2-yl)prop-2-enoyl]amino}-2-(morpholin-4-yl)benzoate |
|
Staphylococcus |
Others |
Preclinical (in vitro) |
Chenna BC, et al. 2010. Eur J Med Chem |
|
methyl 5-[[(E)-3-(furan-2-yl)prop-2-enoyl]amino]-2-piperidin-1-ylbenzoate |
Depiction based on curated SMILES
N
O
CH
3
O
N
H
O
O
|
Staphylococcus |
Others |
Preclinical (in vitro) |
Chenna BC, et al. 2010. Eur J Med Chem |
|
N-[2-(2-aminopyrimidin-5-yl)phenyl]-3,5-dibromobenzamide |
Depiction based on curated SMILES
N
Br
Br
NH
2
O
NH
N
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Weig AW, et al. 2021. RSC Med Chem |
|
N-[3-(2-aminopyrimidin-4-yl)phenyl]-3,5-dibromobenzamide |
Depiction based on curated SMILES
N
Br
Br
H
2
N
O
N
H
N
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Weig AW, et al. 2021. RSC Med Chem |
|
N-[3-(2-aminopyrimidin-4-yl)phenyl]-3,5-dichlorobenzamide |
Depiction based on curated SMILES
N
Cl
Cl
H
2
N
O
N
H
N
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Weig AW, et al. 2021. RSC Med Chem |
|
N-[3-(2-aminopyrimidin-4-yl)phenyl]-3-bromo-5-chlorobenzamide |
Depiction based on curated SMILES
N
Cl
Br
O
NH
2
HN
N
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Weig AW, et al. 2021. RSC Med Chem |
|
N-[3-(2-aminopyrimidin-5-yl)phenyl]-3,5-dibromobenzamide |
Depiction based on curated SMILES
N
Br
Br
NH
2
O
N
H
N
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Weig AW, et al. 2021. RSC Med Chem |
|
N-[4-(2-aminopyrimidin-4-yl)phenyl]-3,5-dichlorobenzamide |
Depiction based on curated SMILES
O
N
Cl
Cl
NH
2
N
H
N
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Weig AW, et al. 2021. RSC Med Chem |
|
| | |
| | |
| | |
| | |
| | |